INFORM
consortium proposes

INFORM consortium proposes to investigate explainable artificial intelligence (XAI) with a dual aim of i) building high performance DNN-based classifiers and ii) developing novel interpretability techniques for radiomics.

01

Τo overcome the limited amount of data typically available in radiomics, INFORM investigates Monte Carlo (MC) simulations combined with generative adversarial networks (GAN) for producing large amounts of highly realistic simulated images to facilitate training DNNs.

02

Τo overcome the limited amount of data typically available in radiomics, INFORM investigates Monte Carlo (MC) simulations combined with generative adversarial networks (GAN) for producing large amounts of highly realistic simulated images to facilitate training DNNs.

03

INFORM proposes to build explainable AI models that incorporate both conventional radiomics and DNN-based features.

04

Preliminary evaluation will be carried out with the help of clinical collaborators on predicting outcome of patients with lung, cervical and rectal cancer. Leverage the robustness and trustworthiness of expert-derived features.

 

Overall, INFORM’s methodological research and clinical application will advance interpretability of feature engineering, generative models, and DNN classifiers with applications in radiomics and broad medical imaging.

Our team of Big Thinkers

Rudy Horne

Founder, Brand Strategist

Sabrina Philip

Creative Director

Teegan Squires

Web Designer

Cruz Lowry

Digital Marketing Manager

This project is supported by the CHIST-ERA  grant [CHIST-ERA-19-XAI-007]

With project acronym INFORM, by:

  1. General Secretariat for Research and Innovation (GSRI) of Greece [T12ΕΡΑ5-00053],
  2. National Science Centre (NCN) of Poland [2020/02/Y/ST6/00071] and,
  3. Agence Nationale de la Recherche (ANR) of France.

 supported by

Let’s get creative

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed auctor turpis eu arcu sagittis, id sagittis justo suscipit. Aliquam erat volutpat. Integer finibus sem

© 2022 All Rights Reserved.